NSEGeneral Updates15h ago · 1 Sept 2026, 12:04 pm
General Updates
Sakar Healthcare Limited · SAKAR
✦ AI Summary▲ PositiveOrder Win
Sakar Healthcare Limited has received 14 oncology product new approvals in the EU, UK, and Canada with 7 business partners, enhancing its coverage in treating various cancer types.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sakar Healthcare Limited has informed the Exchange about Sakar receives 14 oncology product new approvals in the EU (Europe), UK & Canada with 7 business partners
Attachments (1)
📄pdf
Download →
SAKAR_01092026120323_Announcement.pdf
View document text
Sakar
Certified ISO 9001 :2015 by
Healthcare Limited
Corporate Office:
406, Silver Oaks Cornm. Complex,
Opp.Arun Society, Paldi,
Ahmedabad-380 007. Gujarat, India.
Phone : 079-26584655
CINNo. : L24231GJ2004PLC04386I
E-mail: info@sakarhealthcare.com
Date: 1st Septem ber 2026 Web : www.sakarhealthcare.com
The Manager
Listing Compliance Department
ational Stock Exchange of India Ltd.
Exchange Plaza, Bandra Kurla Complex,
Bandra (E), Mumbai-400051, India
Symbol: SAKAR
SUB: Sakar receives 14 oncology product new approvals in the EU (Europe), UK &
Canada with 7 business partners
Dear All,
Sakar Healthcare Ltd. continues to make steady progress in its strategic initiatives, reflecting
strong business momentum and positioning the company for sustained long-term growth. In this
advancement:
• Accord has been the front runner partner with another 5 products site variations to Sakar's
manufacturing site approved by EMA- taking the count to total 6 of 8 technology transfer
they initiated
• Other 2 partners located in the UK and 1 in Germany have also successfully received
approval of their 3 products from MHRA and EMA
• Additionally 6 of Sakar's licensed out products have been granted Marketing
Authorizations ofwhich 4 are in the EU, I each in the UK and Canada
• These approvals have significantly enhanced the coverage to treating various cancer types
including breast, lung, prostrate, stomach, head & neck, colon & rectum, ovary, liver,
kidney, thyroid, blood, bone-marrow and lymph
With this noticeable progress inthe regulated markets of the EU, UK & Canada, Sakar is well set
to strengthen its position leveraging both the business models to gear up top-line sales.
We do appreciate your encouragement, support and guidance during this formative phase.
Thank you.
Yours faithfully,
FOR, SAKAR HEAt.~~::KE LIMITED
BHARATSONI
COMPLIANCE OFFI
Regd. Office / Works: Block No.1 0-13, Sarkhej-Bavla Road, Village Changodar, Dist. Ahmedabad - 382 213. India.
Phone : +91 99091 53977